Photodynamic Therapy (PDT)
Omnilux™ has developed a new and exciting therapy, combining low concentrations of a naturally occurring photosensitizer and light, to offer a unique and effective photofacial.
Using variable or mosaic concentrations of a photosensitizer combined with Omnilux™ light we are able to offer a safe and effective treatment for the reduction of fine lines and wrinkles, removal of pigmentation and super smooth skin. Patients see varying degrees of efficacy according to the photosensitizer concentration used and the time of photosensitizer contact. This allows the physician to tailor the treatment regimes according to the individual skin type, degree of damage and the downtime that the patient is prepared to accept.
How Omnilux Works
Why choose Omnilux™ for Photofacials?
Light therapy in combination with a photosensitizer stimulates phototoxic activity leading to an increase in cellular activity and specific growth factors.
These growth factors lead to the stimulation of dermal fibroblasts and keratinocytes that synthesize collagen and elastin.
The result is reduced fine lines and wrinkles and a marked reduction in skin roughness, improving tone and leaving the skin markedly smoother.
Before and after Omnilux™ photodynamic photorejuvenation showing drastic reduction in fine lines and wrinkles, improved skin texture and clearance of photo damaged skin.
In a recent clinical Study, subjects with moderate fine lines and wrinkles (crowsfeet) in the periorbital region were enrolled. Skin was exfoliated before application of the photosensitizer to enhance its absorption. Subjects received a single topical application of 5% 5-ALA for 30 minutes followed by a single 20-minute light treatment, at 633 nm, 96J/cm2. Assessments were made at 1, 4, 8 and 12 weeks after the treatment concluded.
67% of subjects had a significantly successful treatment response, with a reduction in fine lines and wrinkles and a smoothing of the skin in the periorbital region. The treatment was well tolerated with no adverse events.
The treatment appears safe and reproducible. All patients developed mild post inflammatory erythema between day 1 and 3, which resolved in all by at least day 7. All patients experienced some mild peeling of skin. However the degree of erythema and pain during the treatment is dependent upon the concentration of the photosensitizer and the contact time.